US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicara Therapeutics

18.51

+0.73004.11%

Post-market: 17.05-1.4600-7.89%19:44 EDT

Volume:949.57K

Turnover:17.75M

Market Cap:1.01B

PE:-7.87

High:19.71

Open:18.55

Low:17.46

Close:17.78

52wk High:28.09

52wk Low:7.80

Shares:54.61M

Float Shares:24.13M

Volume Ratio:1.69

T/O Rate:3.93%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3513

EPS(LYR):-4.0460

ROE:-32.71%

ROA:-22.85%

PB:2.32

PE(LYR):-4.57

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv

Bicara Shares Rise Premarket on FDA Breakthrough Designation

Bicara Therapeutics Receives FDA Breakthrough Therapy Designation for Ficerafusp Alfa in First-Line HPV-Negative Head and Neck Cancer

Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L Hpv-Negative R/M Hnscc

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BCAX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","market":"US","secType":"STK","nameCN":"Bicara Therapeutics","latestPrice":18.51,"timestamp":1760385600000,"preClose":17.78,"halted":0,"volume":949574,"hourTrading":{"tag":"盘后","latestPrice":17.05,"preClose":18.51,"latestTime":"19:44 EDT","volume":10773,"amount":198198.6507,"timestamp":1760399094758},"delay":0,"floatShares":24134001,"shares":54612477,"eps":-2.351251,"marketStatus":"Closed","change":0.73,"latestTime":"10-13 16:00:00 EDT","open":18.55,"high":19.71,"low":17.4563,"amount":17754873.51915,"amplitude":0.126755,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.351251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760428800000},"marketStatusCode":5,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":17.78,"preHourTrading":{"tag":"盘前","latestPrice":18.85,"preClose":17.78,"latestTime":"09:29 EDT","volume":43755,"amount":902131.66398,"timestamp":1760362199929},"postHourTrading":{"tag":"盘后","latestPrice":17.05,"preClose":18.51,"latestTime":"19:44 EDT","volume":10773,"amount":198198.6507,"timestamp":1760399094758},"volumeRatio":1.686882,"impliedVol":0.8156,"impliedVolPercentile":0.7615},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","floatShares":24134001,"roa":"-22.85%","roe":"-32.71%","lyrEps":-4.045991,"volumeRatio":1.686882,"shares":54612477,"dividePrice":0,"high":19.71,"amplitude":0.126755,"preClose":17.78,"low":17.4563,"week52Low":7.8,"pbRate":"2.32","week52High":28.09,"institutionHeld":0,"latestPrice":18.51,"eps":-2.351251,"divideRate":0,"volume":949574,"delay":0,"ttmEps":-2.351251,"open":18.55,"prevYearClose":17.42,"prevWeekClose":17.78,"prevMonthClose":15.79,"prevQuarterClose":15.79,"fiveDayClose":18.03,"twentyDayClose":11.38,"sixtyDayClose":10.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"BCAX","fiscalQuarterEnding":"2025/06","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2025-05-13","symbol":"BCAX","fiscalQuarterEnding":"2025/03","expectedEps":-0.4,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-03-27","symbol":"BCAX","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2024-11-12","symbol":"BCAX","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1757476800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCAX","date":"2025-10-10","current":-7.74056,"percent":0.576208,"low":-22.704836,"twenty":-17.21369,"median":-11.089726,"eighty":-6.337818,"high":-5.144536,"avg":-11.594175,"sd":5.10282,"marketCap":997223830},"quantilePoints":[{"date":"2024-09-13","current":-12.837909,"twenty":-12.837909,"median":-12.837909,"eighty":-12.837909,"marketCap":832435719},{"date":"2024-09-20","current":-20.633135,"twenty":-21.391361,"median":-20.283845,"eighty":-14.007791,"marketCap":1337893755},{"date":"2024-09-27","current":-21.555755,"twenty":-21.594337,"median":-21.446718,"eighty":-19.006626,"marketCap":1397718272},{"date":"2024-10-04","current":-19.962139,"twenty":-21.575885,"median":-21.337681,"eighty":-19.559541,"marketCap":1294385015},{"date":"2024-10-11","current":-15.936161,"twenty":-21.540658,"median":-20.570229,"eighty":-18.732598,"marketCap":1033332575},{"date":"2024-10-18","current":-17.143955,"twenty":-21.466848,"median":-20.283845,"eighty":-16.808457,"marketCap":1111648307},{"date":"2024-10-25","current":-18.964032,"twenty":-21.403103,"median":-19.23243,"eighty":-16.959431,"marketCap":1229665764},{"date":"2024-10-31","current":-19.878264,"twenty":-21.362844,"median":-19.23243,"eighty":-17.02653,"marketCap":1288946422},{"date":"2024-11-08","current":-19.79439,"twenty":-21.337681,"median":-19.82794,"eighty":-17.143955,"marketCap":1283507830},{"date":"2024-11-15","current":-20.345116,"twenty":-21.127995,"median":-19.949558,"eighty":-18.418848,"marketCap":1210086831},{"date":"2024-11-22","current":-16.257533,"twenty":-21.102833,"median":-19.82794,"eighty":-17.143955,"marketCap":966965549},{"date":"2024-11-29","current":-19.02049,"twenty":-20.975343,"median":-19.458892,"eighty":-17.009755,"marketCap":1131300719},{"date":"2024-12-06","current":-17.876882,"twenty":-20.695202,"median":-19.01323,"eighty":-17.12047,"marketCap":1063281195},{"date":"2024-12-13","current":-16.509127,"twenty":-20.532485,"median":-19.005969,"eighty":-17.12047,"marketCap":981929844},{"date":"2024-12-20","current":-15.187116,"twenty":-20.493904,"median":-18.892739,"eighty":-16.769874,"marketCap":903299275},{"date":"2024-12-27","current":-17.49263,"twenty":-20.458153,"median":-18.854995,"eighty":-16.764842,"marketCap":1040426635},{"date":"2025-01-03","current":-15.484454,"twenty":-20.399979,"median":-18.727694,"eighty":-16.641786,"marketCap":920984351},{"date":"2025-01-10","current":-13.952019,"twenty":-20.332862,"median":-18.565256,"eighty":-16.325863,"marketCap":829838189},{"date":"2025-01-17","current":-10.868852,"twenty":-20.271506,"median":-18.306879,"eighty":-15.951961,"marketCap":646457553},{"date":"2025-01-24","current":-10.951191,"twenty":-20.22215,"median":-18.224539,"eighty":-15.55307,"marketCap":651354959},{"date":"2025-01-31","current":-11.811185,"twenty":-20.138275,"median":-17.666458,"eighty":-14.949245,"marketCap":702505641},{"date":"2025-02-07","current":-11.52757,"twenty":-20.11652,"median":-17.561246,"eighty":-13.156068,"marketCap":685636799},{"date":"2025-02-14","current":-12.003311,"twenty":-19.978914,"median":-17.49263,"eighty":-12.003311,"marketCap":713932921},{"date":"2025-02-21","current":-12.643731,"twenty":-19.965494,"median":-17.085242,"eighty":-11.997822,"marketCap":752023854},{"date":"2025-02-28","current":-11.307997,"twenty":-19.942009,"median":-16.815614,"eighty":-11.891694,"marketCap":672577050},{"date":"2025-03-07","current":-14.409462,"twenty":-19.890007,"median":-16.73236,"eighty":-11.891694,"marketCap":857045999},{"date":"2025-03-14","current":-12.213735,"twenty":-19.838005,"median":-16.60519,"eighty":-11.893524,"marketCap":726448513},{"date":"2025-03-21","current":-11.975864,"twenty":-19.8011,"median":-16.394587,"eighty":-11.882546,"marketCap":712300452},{"date":"2025-03-28","current":-10.745093,"twenty":-19.525992,"median":-16.092853,"eighty":-11.882546,"marketCap":730612568},{"date":"2025-04-04","current":-9.486153,"twenty":-19.364339,"median":-15.936742,"eighty":-11.721526,"marketCap":645010946},{"date":"2025-04-11","current":-8.139007,"twenty":-19.311424,"median":-15.55307,"eighty":-11.500123,"marketCap":553411758},{"date":"2025-04-17","current":-9.430022,"twenty":-19.133936,"median":-15.269456,"eighty":-11.355571,"marketCap":641194313},{"date":"2025-04-25","current":-12.533268,"twenty":-19.02049,"median":-15.045308,"eighty":-11.297018,"marketCap":852199585},{"date":"2025-05-02","current":-11.795546,"twenty":-19.011777,"median":-14.409462,"eighty":-11.329955,"marketCap":802038125},{"date":"2025-05-09","current":-10.531076,"twenty":-18.980807,"median":-14.002338,"eighty":-11.242349,"marketCap":716060542},{"date":"2025-05-16","current":-8.546663,"twenty":-18.933837,"median":-13.265854,"eighty":-11.091295,"marketCap":789139074},{"date":"2025-05-23","current":-9.249533,"twenty":-18.888545,"median":-12.837909,"eighty":-10.95668,"marketCap":854037173},{"date":"2025-05-30","current":-5.575709,"twenty":-18.86506,"median":-12.634583,"eighty":-10.80298,"marketCap":514821897},{"date":"2025-06-06","current":-6.514837,"twenty":-18.854995,"median":-12.506498,"eighty":-10.643069,"marketCap":601534484},{"date":"2025-06-13","current":-6.833787,"twenty":-18.81138,"median":-12.341819,"eighty":-10.421008,"marketCap":630984042},{"date":"2025-06-20","current":-5.569802,"twenty":-18.738652,"median":-12.190862,"eighty":-10.145292,"marketCap":514276535},{"date":"2025-06-27","current":-5.203601,"twenty":-18.705007,"median":-12.094799,"eighty":-9.441248,"marketCap":480464080},{"date":"2025-07-03","current":-5.333543,"twenty":-18.687321,"median":-12.003311,"eighty":-9.12531,"marketCap":492462048},{"date":"2025-07-11","current":-5.859219,"twenty":-18.443191,"median":-11.975864,"eighty":-8.617541,"marketCap":540999282},{"date":"2025-07-18","current":-6.881039,"twenty":-18.418848,"median":-11.920971,"eighty":-8.339475,"marketCap":635346939},{"date":"2025-07-25","current":-7.04642,"twenty":-18.306879,"median":-11.898098,"eighty":-7.625808,"marketCap":650617080},{"date":"2025-08-01","current":-6.562089,"twenty":-18.251986,"median":-11.884376,"eighty":-7.016887,"marketCap":605897381},{"date":"2025-08-08","current":-6.0246,"twenty":-18.224539,"median":-11.847781,"eighty":-6.881039,"marketCap":556269423},{"date":"2025-08-15","current":-6.063601,"twenty":-17.876882,"median":-11.795546,"eighty":-6.786535,"marketCap":622562015},{"date":"2025-08-22","current":-6.180515,"twenty":-17.675607,"median":-11.648291,"eighty":-6.638873,"marketCap":634565840},{"date":"2025-08-29","current":-6.329315,"twenty":-17.657309,"median":-11.619058,"eighty":-6.514837,"marketCap":649843436},{"date":"2025-09-05","current":-6.409029,"twenty":-17.584119,"median":-11.52757,"eighty":-6.407746,"marketCap":658027862},{"date":"2025-09-12","current":-6.366515,"twenty":-17.562161,"median":-11.3858,"eighty":-6.401771,"marketCap":653662835},{"date":"2025-09-19","current":-5.877601,"twenty":-17.506353,"median":-11.36289,"eighty":-6.371769,"marketCap":603465021},{"date":"2025-09-26","current":-5.686286,"twenty":-17.49263,"median":-11.294273,"eighty":-6.328252,"marketCap":583822398},{"date":"2025-10-03","current":-8.880173,"twenty":-17.49263,"median":-11.226216,"eighty":-6.328252,"marketCap":911745073},{"date":"2025-10-10","current":-9.712715,"twenty":-17.21369,"median":-11.089726,"eighty":-6.337818,"marketCap":997223830}],"updateTime":1760369171664},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCAX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575281804","title":"BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv","url":"https://stock-news.laohu8.com/highlight/detail?id=2575281804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575281804?lang=en_us&edition=fundamental","pubTime":"2025-10-14 01:46","pubTimestamp":1760377569,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, VertivEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nL6N3VU0HC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","TVRD","MACW.SI","NPO","LU0496367417.USD","TGT","KDP","SCCO","NDRA","BK4567","XOM","FAST","BK4500","BK4566","AGX","CVX","NEM","PGEN","DVN","LNT","SRRK","BK4155","STUB","STX","LU2054465674.USD","ALK","LU0878866978.SGD","COP","JEF","ABEO","BCAX","CERO","LU1571399168.USD","MKSI","ARDX","SG9999014542.SGD","VRT"],"gpt_icon":1},{"id":"2575405295","title":"Bicara Shares Rise Premarket on FDA Breakthrough Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2575405295","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575405295?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:04","pubTimestamp":1760357040,"startTime":"0","endTime":"0","summary":"Shares of Bicara Therapeutics rose sharply in premarket trading Monday after the clinical-stage biopharmaceutical company won U.S. Food and Drug Administration breakthrough-therapy designation for its lead program, ficerafusp alfa, in certain head and neck cancers.Bicara on Monday said the designation covers ficerafusp alfa in combination with Merck's blockbuster cancer drug Keytruda for first-line treatment of patients with metastatic or with unresectable, recurrent head and neck squamous cell carcinoma that is human papillomavirus-negative.The Boston company said HPV-negative head-and-neck squamous cell carcinoma has particularly poor outcomes and limited therapeutic options.The FDA's breakthrough-therapy designation aims to expedite the development and review of a drug for serious conditions when preliminary clinical evidence shows the drug might offer substantial improvement over available therapies.Bicara shares, which closed Friday at $17.78, were recently up 40% to $24.98 in pre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014575.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU2023250843.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","BK4588","SG9999002232.USD","LU0070302665.USD","LU0238689110.USD","LU0106261372.USD","SG9999001176.SGD","IE00BLSP4452.SGD","SG9999014567.USD","MRK","LU1066051225.USD","LU0006306889.USD","BCAX","IE00B2B36J28.USD","LU1941712264.USD","LU0965509101.SGD","IE00B4R5TH58.HKD","LU1069347547.HKD","LU0234572021.USD","LU0965508806.USD","LU1917777945.USD","LU0208291251.USD","IE0002141913.USD","LU1023059063.AUD","SG9999015341.SGD","LU1974910355.USD","LU0203345920.USD","LU0320765489.SGD","LU1061106388.HKD","LU2324357040.USD","LU0265550359.USD","LU1116320737.USD","LU1699723380.USD","LU1093756325.SGD","LU1093756168.USD","LU2361045086.USD","LU1934455194.USD","LU0265550946.USD","LU0211331839.USD","LU1941712348.USD","LU1989772840.SGD","LU0266013472.USD","LU1430594728.SGD","IE0009355771.USD","BK4534"],"gpt_icon":0},{"id":"2575354403","title":"Bicara Therapeutics Receives FDA Breakthrough Therapy Designation for Ficerafusp Alfa in First-Line HPV-Negative Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2575354403","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575354403?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:31","pubTimestamp":1760355073,"startTime":"0","endTime":"0","summary":"Bicara Therapeutics Receives FDA Breakthrough Therapy Designation for Ficerafusp Alfa in First-Line HPV-Negative Head and Neck Cancer. Bicara Therapeutics Inc. announced that the U.S. Food and Drug Administration  has granted Breakthrough Therapy Designation  to ficerafusp alfa in combination with pembrolizumab for the first-line treatment of patients with metastatic or unresectable, recurrent head and neck squamous cell carcinoma  whose tumors express PD-L1 , excluding HPV-positive oropharyngeal squamous cell carcinoma. The designation is based on promising results from multiple Phase 1/1b cohorts, which demonstrated significant clinical benefit and a favorable safety profile. This regulatory milestone is intended to expedite the development and review of ficerafusp alfa, highlighting its potential to address an urgent unmet need in HPV-negative HNSCC. The grant was announced solely by Bicara Therapeutics Inc.Disclaimer: This news brief was created by Public Technologies  using genera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDL6ZTwR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","LU2095319765.USD","NDAQ","IE00B3QW5Z07.USD","BK4585","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4588","BCAX","BK4139"],"gpt_icon":0},{"id":"2575403887","title":"Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L Hpv-Negative R/M Hnscc","url":"https://stock-news.laohu8.com/highlight/detail?id=2575403887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575403887?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:30","pubTimestamp":1760355058,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nTUA1QFSQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCAX","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BCAX\",params:#limit:6,delay:false,,,undefined,":[]}}